Bayer stops blood thinner drug trial for lack of effect in major setback, World News - AsiaOne
Por um escritor misterioso
Descrição
Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug for lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing its most promising medium-term development project in doubt. It said in a statement late on Sunday that experimental anticoagulant asundexian, which it had hoped would generate annual sales of more than 5 billion
Launching Global Virtual MarTech Exchange Summit APAC & EMEA taking place on 7 December 2023, Business News - AsiaOne
Asia-Pacific countries begin to ease pandemic-related travel bans, but hurdles remain, World News - AsiaOne
Blood Thinners Recalled Over Cancer-Causing Impurity
Messi says he struggled to adapt after PSG move, some fans treated him differently, World News - AsiaOne
Lingnan scholars listed in World's Top 2% Scientists by Stanford University, Business News - AsiaOne
Pakistan confirms its first case of mpox, Asia News - AsiaOne
US CDC says new Covid-19 lineage could cause infections in vaccinated individuals, World News - AsiaOne
Bayer shares plunge after blood-thinning drug trial halted
Brandstars Announces '2022 Korea Representative Brand', Business News - AsiaOne
DHL Global Forwarding Asia Pacific certified as Top Employer 2022 third time in a row, Business News - AsiaOne
Former Brazil President Bolsonaro applies for US tourist visa, World News - AsiaOne
Reunite in Nuanor! Pre-register Revelation M and get ready for the Close Beta to unveil endless surprises!, Business News - AsiaOne
You think you need more sleep? Tell that to an elephant seal, World News - AsiaOne
Philippines' Marcos says Myanmar a difficult problem for Asean, Asia News - AsiaOne
McLaren boss says F1 budget cap breach amounts to cheating, World News - AsiaOne
de
por adulto (o preço varia de acordo com o tamanho do grupo)
